Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol

Pulmonary fibrosis is a chronic and irreversible scarring disease in the lung with poor prognosis. Few therapies are available; therefore it is critical to identify new therapeutic targets. Our lab has previously identified the enzyme lactate dehydrogenase-A (LDHA) as a potential therapeutic target...

Descripción completa

Detalles Bibliográficos
Autores principales: Judge, Jennifer L., Nagel, David J., Owens, Kristina M., Rackow, Ashley, Phipps, Richard P., Sime, Patricia J., Kottmann, R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967738/
https://www.ncbi.nlm.nih.gov/pubmed/29795645
http://dx.doi.org/10.1371/journal.pone.0197936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967738/
https://www.ncbi.nlm.nih.gov/pubmed/29795645
http://dx.doi.org/10.1371/journal.pone.0197936

Ejemplares similares